• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAC

Racura Oncology Ltd - Discussion

2.67% ! $2.19
Market Cap $440.0M  !
Healthcare Biotechnology
Add to My Watchlist

Corporate Spotlight


View the full Corporate Spotlight arrow Created with Sketch.

Racura Oncology Ltd

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
refresh Created with Sketch. REFRESH

Featured News

NEWS Watch the Latest Video Interviews here on HotCopper
right-arrow Created with Sketch.
NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$2.19 		Change
-0.060(2.67%) 		Mkt cap ! $440.0M
Open High Low Volume
$2.25 $2.25 $2.17 38.50K

Buyers (Bids)

Vol. Price($)
999 $2.15
 

Sellers (Offers)

Price($) Vol.
$2.20 464
Last trade - 16.10pm 28/08/2026 (20 minute delay) ?
RAC (ASX) Chart

Top Stories

Nova Minerals achieves key milestone on path to Alaskan antimony production

Nova Minerals has shipped key processing and refining equipment to its Port MacKenzie plant site by barge from Seattle.
Imricor Med and Philips launch commercial iMR lab solution Imricor Medical Systems has launched a new Interventional MR (iMR) lab solution in collaboration with Dutch company Royal Philips.
Capital Compass: Askari Metals advances Ethiopia strategy as permitting remains key focus Askari Metals Executive Director Gino D’Anna discusses the company’s Ethiopia strategy, permitting progress, and broader portfolio ambitions.
Senetas experiences stronger cash flow as revenue rises, flags FY27 sales pipeline Senetas has reported 4.7% FY26 revenue growth to $20.2 million, with operating cash flow turning positive and a strong FY27 sales pipeline.
Memphasys receives early Thai FDA Felix approval Memphasys' Felix System has received earlier than anticipated approval from the Thai Food and Drug Administration.

Featured News

NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Watch the Latest Video Interviews here on HotCopper
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.